The Protective Role of Interleukin-33 in Myocardial Ischemia and Reperfusion Is Associated with Decreased HMGB1 Expression and Up-Regulation of the P38 MAPK Signaling Pathway
Published 2015 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
The Protective Role of Interleukin-33 in Myocardial Ischemia and Reperfusion Is Associated with Decreased HMGB1 Expression and Up-Regulation of the P38 MAPK Signaling Pathway
Authors
Keywords
Apoptosis, Inflammation, MAPK signaling cascades, Reperfusion, Cytokines, Jugular vein, Veins, Ischemia
Journal
PLoS One
Volume 10, Issue 11, Pages e0143064
Publisher
Public Library of Science (PLoS)
Online
2015-11-17
DOI
10.1371/journal.pone.0143064
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Depletion of PHD3 protects heart from ischemia/reperfusion injury by inhibiting cardiomyocyte apoptosis
- (2015) Liang Xie et al. JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY
- Ketamine reduces LPS-induced HMGB1 via activation of the Nrf2/HO-1 pathway and NF-κB suppression
- (2015) Yonghong Tan et al. Journal of Trauma and Acute Care Surgery
- Ketamine reduces LPS-induced HMGB1 via activation of the Nrf2/HO-1 pathway and NF-κB suppression
- (2015) Yonghong Tan et al. Journal of Trauma and Acute Care Surgery
- An increase of interleukin-33 serum levels after coronary stent implantation is associated with coronary in-stent restenosis
- (2014) Svitlana Demyanets et al. CYTOKINE
- Anti-inflammatory Effect of B-Type Natriuretic Peptide Postconditioning During Myocardial Ischemia–Reperfusion: Involvement of PI3K/Akt Signaling Pathway
- (2014) Gangying Hu et al. INFLAMMATION
- Urocortin-2 suppression of p38-MAPK signaling as an additional mechanism for ischemic cardioprotection
- (2014) Xiu-Fang Gao et al. MOLECULAR AND CELLULAR BIOCHEMISTRY
- The Alarmin Concept Applied to Human Renal Transplantation: Evidence for a Differential Implication of HMGB1 and IL-33
- (2014) Antoine Thierry et al. PLoS One
- Etanercept Attenuates Myocardial Ischemia/Reperfusion Injury by Decreasing Inflammation and Oxidative Stress
- (2014) Mei Yang et al. PLoS One
- The HMGB1–TLR4 axis contributes to myocardial ischemia/reperfusion injury via regulation of cardiomyocyte apoptosis
- (2013) Hua-Sheng Ding et al. GENE
- Dobutamine-mediated heme oxygenase-1 induction via PI3K and p38 MAPK inhibits high mobility group box 1 protein release and attenuates rat myocardial ischemia/reperfusion injury in vivo
- (2013) Jichun Wang et al. JOURNAL OF SURGICAL RESEARCH
- IL-33 Attenuates Anoxia/Reoxygenation-Induced Cardiomyocyte Apoptosis by Inhibition of PKCβ/JNK Pathway
- (2013) Tao Rui et al. PLoS One
- Hmgb1-TLR4-IL-23-IL-17A Axis Promote Ischemia-Reperfusion Injury in a Cardiac Transplantation Model
- (2013) Hongfei Zhu et al. TRANSPLANTATION
- The Alarmin IL-33 Is a Notch Target in Quiescent Endothelial Cells
- (2012) Eirik Sundlisæter et al. AMERICAN JOURNAL OF PATHOLOGY
- Reduction in IL-33 expression exaggerates ischaemia/reperfusion-induced myocardial injury in mice with diabetes mellitus
- (2012) Tao Rui et al. CARDIOVASCULAR RESEARCH
- Interleukin-33 Is hepatoprotective during liver ischemia/reperfusion in mice
- (2012) Nozomu Sakai et al. HEPATOLOGY
- Pre-discharge risk stratification in unselected STEMI: Is there a role for ST2 or its natural ligand IL-33 when compared with contemporary risk markers?
- (2012) Onkar S. Dhillon et al. INTERNATIONAL JOURNAL OF CARDIOLOGY
- β1-Adrenergic receptor-mediated HO-1 induction, via PI3K and p38 MAPK, by isoproterenol in RAW 264.7 cells leads to inhibition of HMGB1 release in LPS-activated RAW 264.7 cells and increases in survival rate of CLP-induced septic mice
- (2011) Yu Mi Ha et al. BIOCHEMICAL PHARMACOLOGY
- Role of IL-33 in inflammation and disease
- (2011) Ashley M Miller Journal of Inflammation-London
- Ethyl pyruvate reduces myocardial ischemia and reperfusion injury by inhibiting high mobility group box 1 protein in rats
- (2011) Xiaorong Hu et al. MOLECULAR BIOLOGY REPORTS
- Minocycline protects against myocardial ischemia and reperfusion injury by inhibiting high mobility group box 1 protein in rats
- (2010) Xiaorong Hu et al. EUROPEAN JOURNAL OF PHARMACOLOGY
- IL-33 Prolongs Murine Cardiac Allograft Survival Through Induction of TH2-Type Immune Deviation
- (2010) Hui Yin et al. TRANSPLANTATION
- Interleukin-33 Prevents Apoptosis and Improves Survival After Experimental Myocardial Infarction Through ST2 Signaling
- (2009) Kenjiro Seki et al. Circulation-Heart Failure
- Modulation of interleukin signalling and gene expression in cardiac myocytes by endothelin-1
- (2009) Arne Yndestad et al. INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY
- The Alarmin Cytokine, High Mobility Group Box 1, Is Produced by Viable Cardiomyocytes and Mediates the Lipopolysaccharide-Induced Myocardial Dysfunction via a TLR4/Phosphatidylinositol 3-Kinase Pathway
- (2009) H. Xu et al. JOURNAL OF IMMUNOLOGY
- High-Mobility Group Box-1 in Ischemia-Reperfusion Injury of the Heart
- (2008) Martin Andrassy et al. CIRCULATION
- Nonmyocardial Production of ST2 Protein in Human Hypertrophy and Failure Is Related to Diastolic Load
- (2008) Jozef Bartunek et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now